Summit Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Summit Therapeutics Inc. (SMMT) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.100.070.350.070.07
Short-Term Investments0.310.110.000.000.00
Cash & Short-Term Investments0.410.190.350.070.07
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.010.000.010.020.01
Total Current Assets0.420.190.660.100.09
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.010.000.00
Goodwill0.000.000.000.000.00
Intangible Assets0.000.000.000.010.01
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.010.010.010.020.01
Total Assets0.440.200.660.110.10
Current Liabilities
Accounts Payable0.000.000.010.010.01
Short-Term Debt0.000.000.020.000.00
Current Portion of Long-Term Debt0.000.000.020.000.00
Accrued Liabilities0.030.010.020.010.00
Deferred Revenue0.000.000.000.010.01
Other Current Liabilities0.030.000.010.010.00
Total Current Liabilities0.040.020.040.030.02
Non-Current Liabilities
Long-Term Debt0.000.100.500.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.010.100.500.000.00
Total Liabilities0.050.130.540.030.02
Stockholders' Equity
Common Stock0.010.010.000.000.00
Retained Earnings-1.21-0.99-0.38-0.30-0.21
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital1.601.070.500.380.29
Shares Outstanding0.740.700.210.100.00
Total Stockholders' Equity0.390.080.130.080.08
Total Liabilities & Equity0.440.200.660.110.10